Tech Company Financing Transactions
Labcyte Funding Round
On 7/25/2005, Labcyte raised $21 million in Series C funding from Cross Atlantic Capital Partners, Abingworth and Alloy Ventures.
Transaction Overview
Company Name
Announced On
7/25/2005
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series C
Investors
Cross Atlantic Capital Partners (Lead Investor) (Sandra Panem)
Proceeds Purpose
Labcyte will use these funds for expanding its rapidly growing, low-volume liquid handling business, which is based on a proprietary technology for using focused acoustics (ultrasound) to precisely transfer nanoliters of liquid.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
170 Rose Orchard Way
San Jose, CA 95134
USA
San Jose, CA 95134
USA
Phone
Website
Email Address
Overview
The Labcyte acoustic liquid handling technology has broad applications in the life sciences including dispensing equipment, assay systems, particle manufacturing, microarrays, and living cell transfer devices.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Fischer-Colbrie
Chief Technical Officer
Richard Ellson
VP - Manufacturing
Keith Love
VP - Product Management
Michael Miller
VP - Sales
Mark Lasinski
Browse more venture capital transactions:
Prev: 7/25/2005: Pertrac venture capital transaction
Next: 7/25/2005: Primarion venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC transactions on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs